Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 13, Issue 9, Pages 1037-1053
Publisher
Future Medicine Ltd
Online
2012-07-28
DOI
10.2217/pgs.12.77
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Patterns for Neovascular Age-Related Macular Degeneration: Analysis of 284 380 Medicare Beneficiaries
- (2012) Lesley H. Curtis et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration
- (2011) Christian Nischler et al. ACTA OPHTHALMOLOGICA
- Treatment of proliferative diabetic retinopathy with anti-VEGF agents
- (2011) Aysha Salam et al. ACTA OPHTHALMOLOGICA
- CFH,VEGFandHTRA1promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration
- (2011) Martin McKibbin et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Evidence of association ofAPOEwith age-related macular degeneration - a pooled analysis of 15 studies
- (2011) Gareth J. McKay et al. HUMAN MUTATION
- VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration
- (2011) Isao Nakata et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Bevacizumab pharmacogenetics in tumor treatment: still looking for the right pieces of the puzzle
- (2011) Guido Bocci et al. PHARMACOGENOMICS
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
- (2010) Prema Abraham et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Age-related macular degeneration: Current and novel therapies
- (2010) Pradeep S. Prasad et al. MATURITAS
- Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
- (2010) James C. Folk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Age-related Macular Degeneration with Polymorphisms in Vascular Endothelial Growth Factor and Its Receptor
- (2010) Alessandro Galan et al. OPHTHALMOLOGY
- C-Reactive Protein and CFH, ARMS2/HTRA1 Gene Variants Are Independently Associated with Risk of Macular Degeneration
- (2010) Johanna M. Seddon et al. OPHTHALMOLOGY
- Complement Factor H and High-Temperature Requirement A-1 Genotypes and Treatment Response of Age-related Macular Degeneration
- (2010) Takashi Tsuchihashi et al. OPHTHALMOLOGY
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population
- (2009) Katarzyna Janik-Papis et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Complement Factor H Y402H and C-Reactive Protein Polymorphism and Photodynamic Therapy Response in Age-Related Macular Degeneration
- (2009) Xuefeng Feng et al. OPHTHALMOLOGY
- Vascular Endothelial Growth Factor Gene Variation and the Response to Photodynamic Therapy in Age-Related Macular Degeneration
- (2009) Ilkka Immonen et al. OPHTHALMOLOGY
- Vascular Endothelial Growth Factor Gene Polymorphisms in Age-related Macular Degeneration
- (2008) Jane-Ming Lin et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
- (2008) A Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy
- (2008) M A Brantley et al. EYE
- Rhesus monkeys and humans share common susceptibility genes for age-related macular disease
- (2008) P. J. Francis et al. HUMAN MOLECULAR GENETICS
- Dégénérescence maculaire liée à l’âge exsudative : efficacité et limites des différents traitements
- (2008) M. Berdugo Polak et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA
- (2008) Lars G Fritsche et al. NATURE GENETICS
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphisms in the Vascular Endothelial Growth Factor Gene and Risk of Age-related Macular Degeneration
- (2008) Sharmila S. Boekhoorn et al. OPHTHALMOLOGY
- Alleles in the HtrA Serine Peptidase 1 Gene Alter the Risk of Neovascular Age-Related Macular Degeneration
- (2008) Margaret M. DeAngelis et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- Predictive role of C677TMTHFRpolymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration
- (2008) Francesco Parmeggiani et al. PHARMACOGENOMICS
- Systemic Complement Activation in Age-Related Macular Degeneration
- (2008) Hendrik P. N. Scholl et al. PLoS One
- PRIMARY INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
- (2008) J FERNANDO AREVALO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
- (2008) Praveen J Patel et al. Trials
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started